Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action
- 5 February 2019
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 66 (5) , e27657
Abstract
Background: Sickle cell disease (SCD) is a chronic multisystem disorder requiring comprehensive care that includes newborn screening (NBS) as the first step of care. Italy still lacks a national SCD NBS program and policy on blood disorders. Pilot single‐center screening programs and a regional targeted screening have been implemented so far, but more evidence is needed in order to impact health policies.Population and methods: NBS was offered to parents of newborns in gynecology clinics in Padova and Monza, tertiary care university hospitals in northern Italy. High‐performance liquid chromatography (HPLC) was performed as the first test on samples collected on Guthrie cards. Molecular analysis of the beta‐globin gene was performed on positive samples.Results: A total of 5466 newborns were enrolled; for 5439, informed consents were obtained. A similar family origin was seen in the two centers (65% Italians, 9% mixed couples, 26% immigrants). Compared with SCD NBS programs in the United States and Europe, our results show a similar incidence of SCD patients and carriers. All SCD patients had a Sub‐Saharan family background; HbS carriers were 15% Caucasians (Italian, Albanians) and 10% from other areas (North Africa–India–South America); carriers of other hemoglobin variants were mainly (47%) from other areas.Conclusions: Our results demonstrate the feasibility of a multicentric NBS program for SCD, give information on HbS epidemiology in two Northern Italian Areas, and support previous European recommendation for a universal NBS program for SCD in Italy: a high incidence of patients and carriers has been detected, with a high percentage of Caucasian carriers, impossible to identify in a targeted NBS.Keywords
This publication has 20 references indexed in Scilit:
- Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatmentPediatric Blood & Cancer, 2015
- Newborn screening for sickle cell diseases in the United States: A review of data spanning 2 decadesSeminars in Perinatology, 2015
- Management of Sickle Cell DiseaseJAMA, 2014
- Parents’ responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screeningEuropean Journal of Human Genetics, 2014
- Newborn Screening for Sickle Cell Disease: Technical and Legal Aspects of a German Pilot Study with 38,220 ParticipantsBioMed Research International, 2014
- Organizing national responses for rare blood disorders: the Italian experience with sickle cell disease in childhoodOrphanet Journal of Rare Diseases, 2013
- ENERCA clinical recommendations for disease management and prevention of complications of sickle cell disease in childrenAmerican Journal of Hematology, 2010
- Positive screening and carrier results for the England-wide universal newborn sickle cell screening programme by ethnicity and area for 2005–07Journal of Clinical Pathology, 2010
- Improved survival of children and adolescents with sickle cell diseaseBlood, 2010
- Hospitalization of children with sickle cell disease in a region with increasing immigration ratesHaematologica, 2008